Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating proliferation of mammary glands

A breast hyperplasia and drug technology, applied in the field of medicine, can solve problems such as overcorrection, and achieve the effects of not easy recurrence, quick effect, and scientific and reasonable prescription

Inactive Publication Date: 2017-05-03
GUIZHOU HUAANTANG PHARMA CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine treatment of mammary gland hyperplasia is to regulate ovarian endocrine or block hormone targets, block the pathogenesis, and relieve symptoms. Therefore, estrogen-suppressing drugs are often used in the treatment plan. The amount and application time of hormones are difficult to properly meet the needs of the disease, and there is often the disadvantage of overcorrecting; improper application will inevitably aggravate the already imbalanced state

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1 of the present invention: a kind of medicine for the treatment of hyperplasia of mammary gland, this medicine is made of the raw material of following weight composition ratio: 15 parts of Prunella vulgaris, 15 parts of Radix Curcuma, 10 parts of Buliuxing, 12 parts of safflower, 15 parts of Salvia miltiorrhiza 10 parts of saponins, 10 parts of licorice, 10 parts of angelica, 10 parts of red peony, 8 parts of Bupleurum, 15 parts of bergamot, 15 parts of anise, and 15 parts of cumin.

Embodiment 2

[0032] Embodiment 2 of the present invention: a kind of medicine for the treatment of mammary gland hyperplasia, this medicine is made of the raw materials of following weight composition ratio: 25 parts of Prunella vulgaris, 25 parts of Radix Curcuma, 20 parts of Wang Buliuxing, 20 parts of safflower, 25 parts of Salvia miltiorrhiza 18 parts of saponins, 20 parts of licorice, 18 parts of angelica, 16 parts of red peony, 16 parts of Bupleurum, 25 parts of bergamot, 25 parts of anise, and 25 parts of cumin.

Embodiment 3

[0033] Embodiment 3 of the present invention: a kind of medicine for the treatment of mammary gland hyperplasia, this medicine is made of the raw materials of following weight composition ratio: 20 parts of Prunella vulgaris, 20 parts of Curcuma curcuma, 16 parts of Wang Buliuxing, 16 parts of safflower, 20 parts of Salvia miltiorrhiza 14 parts of saponins, 15 parts of licorice, 14 parts of angelica, 14 parts of red peony, 12 parts of Bupleurum, 19 parts of bergamot, 20 parts of anise, and 20 parts of cumin.

[0034] When making the medicine of the above examples, mix the medicine, dry it, and pulverize it into a fine powder of about 100 mesh, add refined honey with a weight ratio of 1:1 to the medicine powder, mix evenly, make strips, and form pills at 5 g / pill , beeswax can be sealed.

[0035] Dosage: Take orally, once a day in the morning and evening, take one pill each time, take it with boiled water.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating proliferation of mammary glands. The medicine for treating proliferation of the mammary glands is prepared from the following components comprising, by weight, 15-25 parts of fruit spike of selfheal, 15-25 parts of radix curcumae, 10-20 parts of cowherb seeds, 12-20 parts of safflower, 15-25 parts of roots of red-rooted salvia, 10-18 parts of Chinese honeylocust spine, 10-20 parts of liquorice, 10-18 parts of Chinese angelica, 10-16 parts of red peony roots, 8-16 parts of red thorowax roots, 15-25 parts of fingered citron, 15-25 parts of anise and 15-25 parts of fennel. Clinical observation is conducted for years as follows, 100 patients of hyperplasia of the mammary glands are selected, after the 100 patients take the medicine for three months, the statistic result shows that 63 patients are clinically cured, the clinical curing rate is 63%, the medicine acts on 34 patients, the effective rate is 34%, and the medicine is ineffective on three patients; and detection results prove that the medicine is significantly effective after the patient takes the medicine for about 2 weeks, and symptoms disappear or are relieved after two months, the total effective rate is 97%, and relapse is not prone to happen.

Description

technical field [0001] The invention relates to a medicine for treating mammary gland hyperplasia, which belongs to the technical field of medicines. Background technique [0002] Breast hyperplasia is the most common breast disease in women, and its incidence rate accounts for the first place in breast diseases. In recent years, the incidence of the disease has been increasing year by year, and the age is getting younger and younger. In adolescent or young women, there is breast distending pain before menstruation, and sometimes the pain spreads to the shoulder and back. After menstruation, the breast pain gradually relieves itself, and only some thickening of the breast can be felt without obvious nodules. These are physiological changes, not The disease does not require treatment, and it is a physiological hyperplasia. Mammary gland hyperplasia is the physiological hyperplasia and incomplete involution of normal mammary gland lobules, and the normal structure of the mam...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P15/14
Inventor 丁伟游德仙王京华
Owner GUIZHOU HUAANTANG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products